Cargando…

Heart rate reduction with esmolol in septic shock: effects on myocardial performance

Detalles Bibliográficos
Autores principales:	Morelli, A, D'Egidio, A, Orecchioni, A, Maraffa, E, Romano, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068212/ http://dx.doi.org/10.1186/cc13352

Ejemplares similares

Heart rate reduction with esmolol in septic shock: effects on microcirculation
por: Morelli, A, et al.
Publicado: (2012)

Human protein C concentrate to restore physiological values in adult septic shock patients: effects on microcirculation
por: Morelli, A, et al.
Publicado: (2012)

Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study
por: Morelli, A, et al.
Publicado: (2008)

Glibenclamide dose response in patients with septic shock
por: Morelli, A, et al.
Publicado: (2007)

Effects of simultaneously infused terlipressin and dobutamine in septic shock
por: Morelli, A, et al.
Publicado: (2007)

Extracorporeal co2 removal in hypercapnic patients who fail noninvasive ventilation and refuse endotracheal intubation: a case series
por: Morelli, A, et al.
Publicado: (2015)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Heart rate variability in the early resuscitation of septic shock
por: Arnold, RC, et al.
Publicado: (2009)

Effects of vasopressinergic V1 receptor agonists on sublingual microcirculatory blood flow in patients with catecholamine-dependent septic shock
por: Morelli, A, et al.
Publicado: (2011)

Immunomodulatory effects of esmolol in a septic animal model due to multidrug-resistant Pseudomonas aeruginosa pyelonephritis
por: Dimopoulos, G, et al.
Publicado: (2008)

Mortality rate reduction associated with severe sepsis and septic shock management protocol implementation
por: Fernandes, Constantino José, et al.
Publicado: (2007)

Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock
por: Du, Wei, et al.
Publicado: (2016)

Effect of vasoactive drugs on the response of the baroreceptor and regulation of heart rate variability in patients with septic shock
por: Nogueira, AC, et al.
Publicado: (2013)

Frequency and clinical spectrum of myocardial dysfunction in severe sepsis and septic shock
por: Pulido, JN, et al.
Publicado: (2010)

Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock
por: Rehberg, S, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
por: Levy, Bruno, et al.
Publicado: (2021)

Prognostic factors of septic shock
por: Quenot, JP, et al.
Publicado: (2012)

Homocysteine levels in septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability
por: Nogueira, AC, et al.
Publicado: (2009)

Sepsis Brazil – early results: albumin and mortality rate in septic shock
por: David, C, et al.
Publicado: (2005)

Effects of early versus delayed terlipressin infusion on hemodynamics and catecholamine requirements in ovine septic shock
por: Kampmeier, TG, et al.
Publicado: (2011)

Effects of vasopressin and terlipressin in ovine septic shock on mesenteric blood flow and survival
por: Rehberg, Sebastian, et al.
Publicado: (2007)

Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock
por: Morelli, Andrea, et al.
Publicado: (2011)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Effect of transfusion, leukocyte-depleted blood product on onset of new septic shock and mortality in septic shock
por: Hayami, H, et al.
Publicado: (2010)

Potential role of poly(ADP-ribose) activation in myocardial contractile dysfunction of human septic shock
por: Nogueira, AC, et al.
Publicado: (2007)

Fluid responsiveness in septic shock
por: Righetti, F, et al.
Publicado: (2014)

Burden of septic shock in the uk
por: Andersson, F, et al.
Publicado: (2015)

Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock
por: Wei, Chaojie, et al.
Publicado: (2016)

Mortality rate of vasopressor-dependent septic shock from 1997 through 2006
por: Afessa, B, et al.
Publicado: (2009)

Mortality reduction in patients with severe sepsis and septic shock through a comprehensive sepsis initiative
por: Nguyen, K, et al.
Publicado: (2014)

Serum lipids analysis in septic shock patients
por: Cappi, S, et al.
Publicado: (2004)

Serum lipids analysis in septic shock patients
por: Nogueira, AC, et al.
Publicado: (2007)

Altered T-cell repertoire diversity in septic shock patients
por: Takeyama, N, et al.
Publicado: (2014)

Dynamic myocardial depression in septic cardiomyopathy
por: Darawshe, A, et al.
Publicado: (2014)

Prognosis value of biomarkers in severe sepsis and septic shock
por: De La Torre-Prados, MV, et al.
Publicado: (2015)

Early use of immunoglobulin in septic shock
por: Cavazzuti, IC, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_em72vbmph36akg5nlv3mtf5jds